In 2014 the percentage of ASAlaser’s devices for "Human" and "Vet" sectors installed worldwide has increased. Today MLS®, Hilterapia® and Magneto Therapy, thanks to their technology and their operational performance, are in force in some of the most prestigious international structures (clinics and hospitals), where doctors and specialists have been able to learn notions about their best use and their potential, participating in targeted training organized by the Company. For ASAlaser, in fact, innovation means not only building high performance machines as result of better technology, but also providing the knowledge to be able to take full advantage of them. Thanks to this added value, the company, compared to 2013, has recorded a 16% sales growth of "Human" devices for Hilterapia® (+ 17%), MLS® (+ 10%) and Magneto Therapy (+47%). Europe leads the equipment installations for Laser Therapy, followed by the U.S.. The positive feedback received by the therapies and the devices has been also confirmed by the opening in 2014 of new markets distributed to the four corners of the world: Indonesia, Australia, Bolivia, Peru, Mexico and India.
Even the veterinarian sector meets the expectations, ending the year with confirmation of the U.S. leadership for the number of Mphi Vet installed, strictly followed by Sweden and Italy. The market opening to the Vet field of some European (Britain, France and Germany), South American (Brazil) and Oceania (Australia) countries leaves hope for a great 2015.
«The results obtained in 2014 - says Lucio Zaghetto CEO of ASAlaser - are the outcome of a strategy that combines the commercial aspects with the formative ones. Last year ASAlaser’s staff flew into the world to kick off courses and masters with its distributors and customers. Many international training have been organized for the Human sector and they have involved, among others, professionals from Russia, Thailand, U.S., South Africa, Poland and Greece. Even the veterinarian field has been characterized by training, thanks to targeted courses for doctors and specialists. Overall, between the human and the veterinarian sector, the missions that have seen our trainers “on stage” have been over 50. A relevant number which confirms that continuous training is a process that involves all the company, as direct result of the research able to give real-time indications. It is strategic for us, as not only allows to accompany the evolution of biomedical technologies, but also to constantly improve the therapeutic results. That’s why even for 2015 training will be an element of value on which we will focus».
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.